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ABSTRACT
In this report we set out to extend recent studies on 
substituted PAC analogues produced by the fermentation of 
aromatic aldehydes with Saccharomyces cerevisiae. The 
medium selected contained glucose as a carbon source for 
the biotransformation, and sodium pyruvate as an inhibitor 
for alcohol dehydrogenase, the enzyme responsible for the 
conversion of the carbinol to a benzyl alcohol derivatives. 
An investigation of sodium cyanoborohydride for a selective 
reductive amination was carried out on these carbinols to 
produce the corresponding ephedrine analogues. Poor 
selectivity was apparent for this reagent but when the 
reduction products were converted to their hydrochloride 
derivatives the optically pure compounds separated readily 
by fractional crystallisation. Their pharmacological 
activity was investigated using commercial ephedrine as a 
reference compound. The synthesised (-) ephedrine had an 
identical activity to the commercial compound, while the 
substituted analogues all had a slightly lower activity, 
with the exception of (-)-4-chloro ephedrine which showed 
a stronger antispasmodic effect. The stereoselectivity of 
the synthesis and the enantiomeric purity of the resolved 
compounds were investigated by high field nuclear magnetic 
resonance spectrometry employing chiral praseodymium shift 
reagents .
LIST OF ABBREVIATIONS
PAC Phenylacetylcarbinol
THF Tetrahydrofuran
Ac Acetyl
Pd/c Palladium on charcoal
UV Ultra Violet
HPLC High Performance Liquid Chromatography
NMR 1 H Proton Magnetic Resonance
NMR 13 C Carbon 13 Magnetic Resonance
hfc Tris(3-heptafluoropropylhydroxymethylene)-d-
camphorato
tfc Tris(3-(trifluoromethylhydroxymethylene)-d-
camphorato
fod Tris(6,6,7,7,8,8,8,-heptafluoro-2,2-dimethyl-
3,5,octanedionato)
ATP Adenosine Tri Phosphate
cAMP 3',5'-cyclic adenosine Mono Phosphate
CNS Central Nervous System
TLC Thin Layer Chromatography
ppm Parts Per Million
[a]„ Specific Optical Rotation (sodium D line)
Rf Retention Value on TLC plate
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INTRODUCTION
1.1 HISTORY The first reported use of ephedrine was in 
China over 5000 years ago as a drug called Ma-huang 
(meaning astringent yellow ) . It was mentioned in herbal 
books as early as 2000 BC. A • Chinese medical plant 
publication in 159 6, recommended the drug for improving bad 
circulation, reducing fever, and treating respiratory 
ailments. The main ingredient in the Ma-huang was dried 
green leaves and shoots from Ephedra sinicra.1
The drug did not appear in the west until Yamanashi 
isolated an impure alkaloid in 1885 and two years later 
Nagai and Hari 2 isolated a pure compound which they named 
ephedrine. Merck of Darmstadt, a German firm, began to 
investigate a European plant Ephedra helvetica and in 1888 
isolated ephedrine and i|r-ephedrine.
Chen, a Chinese American, and his colleague Schmidt studied 
Ma-huang in Peking, and on returning to America in 1923 
began pharmacological trials on native American Ephedra 
species. It is now known that of the 45 species in the 
Ephedra genus only 25 contain the alkaloid, which can be 
present in leaves at concentrations of 1-2% . Today
Ephedrine is prepared by synthesis via the reductive 
amination of Phenyl acetyl carbinol (PAC) , which is 
produced by Saccharomyces cerevisiae during the 
fermentation of sugar medium containing benzaldehyde.
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1.2 STRUCTURE AND PROPERTIES
The structure of ephedrine was elucidated using the 
following reasoning,and was first synthesised by Späth.3 The 
molecular formula was known to be C1QH15NO and on oxidation 
benzoic acid was formed thus suggesting it contains a 
benzene ring with only one side chain. When treated with 
nitrous acid ephedrine yielded a nitroso-compound and must 
therefore be a secondary amine, and when heated with 
hydrochloric acid ephedrine forms methylamine and 
propiophenone (1). Scheme 1
2
This still did not fully assign the structure as two 
possible geometric isomers still existed ,(Figure 1.). When 
it was observed that Hofmann exhaustive methylation of 
ephedrine produced sym-methylphenylethylene oxide (2) 
structure A seemed more probable as this had been known to 
undergo hydramine fission. The proof of the final structure 
was gained by the fact that removal of a hydroxyl group 
still gave an optically active product. This was not 
possible with the alternative structures proposed ie. 
structure B. (Figure 1.)
3
Ephedrine or l-phenyl-l-hydroxy-2-methylamino-propane 
contains two asymmetric carbon centres and consequently 
there are four possible isomers. These are divided into two 
classes according to their symmetry . The erythro or 
ephedrine series contains the enantiomers (±)-ephedrine and 
the threo or pseudoephedrine series contains the ( ± ) —i|r — 
ephedrine. The configuration of the pairs of enantiomers 
was first proposed by Freudenberg 4 .( Figure 2.)
4
Ephedrine is a colourless, odourless, waxy compound which 
is deliquescent and partly crystalline. It decomposes 
gradually in the presence of light and atmospheric carbon 
dioxide. The anhydrous material has a melting point of 34°C 
but rapidly absorbs water to form a hemihydrate with a 
slightly higher melting point ( 40°C ). Ephedrine is
volatile at room temperature, is laevorotary and is a 
slightly weaker base (pKa 9.4) than i|i-ephedrine. It is 
soluble in water (one part in 36 @ 20°C), alcohol, organic 
solvents and oils. The free base forms derivatives such as 
hydrobromides, hydrochlorides, phosphates, oxalates, and 
sulphates.5 The individual ephedrine and \|j-ephedrine isomers 
are often characterised as their hydrochloride derivative. 
This data is summarised in Table 1.
(+)ephedrine (-)ephedrine (+) i^-ephedrine (-) if-ephedrine
Melting
point
37°-39°C 37°-39°C 118°-/I'19°C 118°-119°C
R S 
conf i g .
1S 2R 1R 2S 1S 2S 1R 2R
-40°
C=5, 1N HCl
-49°
C=0.6,EtOH
HCl
derivative
HP
218°-220°C 218°-220°C 185°-188°C 185°-188°C
HCl
derivative
Ca]D
+34.3° 
C=5,WATER
+68.0° 
C=0.6, EtOH
Table 1. Properties of the isomers of ephedrine 
and their hydrochloride derivatives
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1.3 CHEMICAL SYNTHESIS
The synthesis by Spats 3 was initiated by the bromination of 
ethanal (3) to give a-bromo ethanal (4) which on refluxing 
in ethanol acidified with hydrogenbromide gave (5). The 
intermediate (6) was produced by the Grignard reaction of 
(5) with phenyl magnesium bromide followed by de- 
bromination using methylamine. Hydrogen iodide removed the 
methoxy group to give (±)-i|i-ephedrine, which was resolved 
using tartaric acid ( Scheme 2).
6
(-)-ephedrine was synthesised by Mansake6 via the catalytic 
reduction of 1-phenylpropane-l,2-dione in a methanolic 
solution of methylamine followed by resolving the racemic 
(±)-ephedrine with mandelic acid.
Another synthetic route to (i|r)-ephedrine used (±)-a- 
methylaminopropiophenone (8) as a precursor. This is 
readily obtained from propiophenone (1) by bromination 
followed by reaction with methylamine. Reduction of the 
ketone with sodium amalgam gives a mixture of (±)- 
ephedrine and (±)-ijr- ephedrine, with the latter in 
slightly higher proportion.7 (Scheme 3 )
7
i|/-ephedrine was converted into ephedrine by heating with 
aqueous hydrochloride solution (25%) in a sealed tube to 
give an equilibrium ratio of 60:40.® This was an important 
discovery as the (-)-ephedrine isomer has a higher 
pharmacological activity than the pseudo isomer
Catalytic reduction of a-methyl aminopropiophenone 
hydrochloride over platinum gives almost exclusively (+)- 
ephedrine in yields of over 90%.9 In this particular case 
the stereoselectivity is based on "kinetic control" as 
ephedrine is formed faster than the pseudo isomer.
( ± )-ephedrine and (±)-i(i-ephedrine.
8
Of the four stereoisomers only ( + )-i|i-ephedrine and (-)- 
ephedrine are pharmacologically active, with the latter 
being of more commercial value. A synthetic route producing 
a predominance of the (-)-isomer was desired, and this was 
achieved by the reductive amination of phenylacetylcarbinol 
(9) with methylamine and hydrogen over a platinum catalyst 
10 , Scheme 4 . (-)Phenylacetylcarbinol can be synthesised
from (-)-methyl mandelate (Scheme 5) by the method of 
Freudenberg 4 , or produced by fermentative mixed acetoin 
condensation between benzaldehyde and acetaldehyde in the 
presence of the pyruvate decarboxylase enzyme found in 
Saccharomyces cerevisiae.
9
A number of authors have published work relating to 
stereospecif ic synthesis of ephedrine and i|i-ephrdrine. 
Buckley 11 used chiral N-ethoxycarbonyl and N-benzene 
sulphonyl derivatives of alanine as the bases for the 
production of various oxygenated aromatic a-amido ketones 
via two routes.
The first route involved converting the a-amino acid 
derivative to the corresponding acid chloride, followed by 
a Friedel-Crafts acylation carried out with phenyl 
magnesium bromide to give the ketone (10) (Scheme 6.)
0
H l l h ^ ^  OH
0
H l l î î V ^ C l PhMgBr
0
Ph
HN
\ / 0R
II
0
► HN
n / or
II
0
A IC I3
*  HN
\ / 0R
II
0 18
EPHEDRINE
LiAlH4
OH
H l î V ^  Ph NaBH4
HN i
\y°*
1
R = Et
0
1 1
Scheme 6. Stereoselective synthesis of ephedrine
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A second method was via an arylmetallo route using phenyl 
lithium and this also produced the ketone (10). The 
products were optically active in each of the above cases.
The stepwise reduction of (S)-2-((ethoxycarbonyl)amino)-1- 
phenyl-propanone (10) afforded variable ratios of ephedrine 
and i|;-ephedrine. In each case the ketone carbonyl was first 
converted to the alcohol (11) using NaBH4 followed by 
reduction with lithium aluminum hydride to give the desired 
secondary amino alcohol. A 4:1 ratio of ephedrine to 
i|i-ephedrine was achieved in a yield of 90 % by this method. 
The ortho, meta methoxyphenyl,and the 2,4 dimethoxyphenyl 
analogue of ketone (10) were also prepared by the Friedel- 
craft method, but these were not reduced to the 
corresponding ephedrine compounds.
Fujita 12 produced optically active 2-amino alcohols by a 
diastereocontrolled reduction using hydrosilanes 
(Scheme 7). In this method dimethylphenyl silane in THF was 
used to reduce the ketone (12) yielding 2-ethoxycarboxyl 
amino-l-phenylpropan-l-ol (13) in a 1:9 threo to erythro 
ratio. Reduction of (13) with lithium aluminium hydride in 
THF at 60°C gave (1)-ephedrine with a yield of 80% . The 
stereochemical outcome is attributed to the bulky reduction 
species which attacks the ketone carbonyl carbon according 
to the Felkin 13 transition state model.
11
Shono 14 reported a stereoselective synthesis of vicinal 
erythro amino alcoholic moieties utilising carbanions in 
which the negative charge is located at a position a to the 
nitrogen atom of the N-acylamine, Scheme 8. The synthesis 
was started by preparing a-methoxy carbamate (14) by the 
anodic oxidation of a-carbomethoxyethylamine in methanol. 
The N-methylation derivative of (14) was followed by 
treatment with chlorodiphenylphosphene to give (15), Scheme 
8. On reaction with benzaldehyde the 2-oxazolidone 
derivative (17) was formed. Careful hydrogenation in the 
presence of Pt02 at atmospheric pressure, for a short period 
gave the highest yields of (18) which on alkaline 
hydrolysis afforded (+)-ephedrine selectively
12
ephedrine
13
A number of researchers have published work relating to the 
synthesis of substituted ephedrine derivatives. Kraft15 
prepared 4-fluoroephedrine hydrochloride as a racemic 
mixture by the platinum oxide catalysed reductive amination 
of N-methylamino 4-fluoropropiophenone (18). The reaction 
sequence is shown below (Scheme 9).
Pfanz 16 reported the synthesis of p-nitro and p-amino 
-ijj-ephedrine hydrochloride in a research paper outlining 
various methods of converting ephedrine from the erythro to
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the threo isomer via the OAc derivative. The 0,N diacetyl- 
iji-ephedrine derivative was nitrated by reacting nitric acid 
( d 1.52 ) and a small quantity of para aminobenzosulphonic 
acid, at 0°C for one hour. Refluxing in 2 M HCl produced 
the hydrochloride derivative, and this was converted to the 
4-amino analogue by the catalytic reduction of the nitro 
group with platinum oxide.
Oamu 17 patented the synthesis and use of
4-(trif luoromethyl )-ephedrine as a cardiovascular [3 
blocking agent. The synthesis involves the halogénation of 
the substituted ethyl phenyl ketone, followed by reaction 
with methylamine. The amino ketone was reduced to the 
corresponding amino alcohol using a Pd/C catalyst.
Weichet 18 synthesised 4-hydroxyphenylacetyl carbinol from 
the intermediate ethynylcarbinol produced by reacting 
acetylene with 4-hydroxybenzaldehyde in liquid ammonia. The 
hydroxy carbinol was then reduced in the presence of methyl 
amine using sodium borohydride to give the corresponding 
ephedrine analogue.
Ose and Takamatsu 19 patented a method of synthesising 
racemic erythro and threo 2-chloroephedrine hydrochloride 
by reducing 2'-chloro-2-methylamino propiophenone with 
lithium aluminium hydride in the presence of methylamine. 
They later patented another method for the production of
15
2-chloro, 3,4 and 2,5 dichloroephedrine hydrochloride which 
used an acidic solution of KC104 in the presence of UV light 
to induce aryl chlorination of ephedrine.
Ziman 20 studied the synthesis of a range of di- and tri­
substituted oxazolinin-2-one oximes, which were patented as 
antidepressants. The 3,5 dimethyl,-5-(4-fluorophenyl) 
derivative (20) was prepared by reacting Phosgene oxime 
0-(N-methyl)-carbamate (19) with the corresponding 
substituted ephedrine (Scheme 10). This in turn was 
synthesised by reacting a substituted benzaldehyde with 
lithium acetylide , and the resulting yne-ol was hydrated 
with mercuric oxide/methanol/water. Reductive amination 
using methylamine and sodiumborohydride/methanol gave the 
ephedrine analogue as a mixture of erythro and threo 
isomers. The 4-chloro, and the 4-fluoro analogue were 
prepared by this method and converted to the substituted 
oxazolinin-2-one oxime.
one oximes
16
1.4 PRODUCTION OF PHENYL ACETYL CARBINOL
Neuberg21 studied the transformation of benzaldehyde to 
benzyl alcohol using broths of fermenting yeast and 
sucrose. After 3-5 days no sugar or benzaldehyde remained 
but the quantity of benzyl alcohol produced was not 
proportional to the original amount of benzaldehyde used. 
They searched for a side product in the fermentation broth 
and found a compound which exhibited leavo-rotation. All 
the tests carried out indicated an optically active a 3 
ketone alcohol.22 This compound was phenylacetylcarbinol.
Further studies showed that the addition of carboxy- 
acetaldehyde improved the yield, and they fermented other 
aldehydes such as cinamaldehyde which led them to the 
conclusion that carboligase was an active enzyme component 
in forming these compounds. Smith23 proposed that 
acetylation of benzaldehyde proceeded via a coenzyme 
dependent system and Hanc24 showed that pyruvic acid 
produced during the fermentation of sucrose is 
decarboxylated to an active acetaldehyde which reacts with 
benzaldehyde in a benzoin condensation reaction mediated by 
an enzyme but requiring a coenzyme thiamine pyrophosphate. 
The enzyme was identified as pyruvate decarboxylase and not 
carboligase as suggested by Neuberg. Magnesium ions (Mg2*)
17
also activated the biotransformation which indicated that 
the enzyme molecule has four coenzyme binding sites, three 
of which are occupied by thiamine pyrophosphate and one by 
magnesium25
Many research workers have studied the bioconversion of 
benzaldehyde to PAC in order to maximise the yield. Smith23 
showed that when pyruvic acid was added in concentrations 
exceeding that of benzaldehyde the latter inhibits the 
production of benzyl alcohol. Groger26 found the maximum 
production of PAC was 5g/L using 20% cane sugar in the 
medium ,but the addition of beer wort increased the yield 
to 8g/L as a result of the high levels of thiamine it 
contains.
Voets27 demonstrated that agitation and aeration of the 
medium during fermentation was important if yields were to 
be maximised, and that in the first 10 hours intensive bud 
formation occurred in the yeast corresponding to the 
period when the highest levels of PAC were produced. The 
possibility of other strains of yeast being used in this 
fermentation was investigated by Netrval28 and he found that 
Saccharmovces calsberoensis could produce up to 12.4g/L of 
PAC. These values only represented analytical and not 
extracted yields. Agarwal29 studied the material balance of 
the medium and suggested that the optimum level of 
benzaldehyde was 16mM. At levels of 4mM or below the
18
production of benzyl alcohol was a maximum while levels 
above 20mM inhibited the production of PAC completely.
The acyloin condensation reaction has also been reported to 
occur with substituted benzaldehydes. Most of the early 
work was carried out by Neuberg22,30 while Groger31 
demonstrated that 1-naphthaldehyde and 2-furaldehyde were 
also substrates for this bioconversion.
Long32 studied the production of substituted PAC's. The 
yield of these compounds, and the corresponding benzyl 
alcohol derivative, were measured colorimetrically and by 
high performance liquid chromatography (HPLC) respectively. 
They demonstrated that the aromatic aldehydes substituted 
in the ortho position were poor substrates, while those 
with -CH3, -CF3, and -Cl substituent located at para
positions produced high carbinol yields. The opposite was 
observed with methoxy substituent, which gave highest 
yields when meta substituted rather than in either of the 
other positions. The measured yields of carbinol compound 
and substituted aromatic alcohol are given in Table 2.
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Substrate 
aromatic aldehyde
L-acetyl aromatic 
carbinol
yield
(mg/mL)
aromatic
alcohol
yield
(mg/mL)
Benzaldehyde L-phenylacetyl
carbinol
10.1-10.2 benzyl alcohol 0.4
o-Tolualdehyde L-2-methylphenyI 
acetyl carbinol
2.0-2.5 2-methylbenzyl
alcohol
1.0
m-Tolualdehyde L-3-methylphenyl 
acetyl carbinol
5.6-6.2 3-methylbenzyl
alcohol
0.4
p-Tolualdehyde L-4-methylphenyl 
acetyl carbinol
5.4-6.4 4-methylbenzyl 
a I cohoL
0.3
2-Chlorobenz-
aldehyde
L-2-chloroacetyl
carbinol
0.6-0.7 2-chlorobenzyl
alcohol
0.8
3-Chlorobenz-
aldehyde
L-3-chloroacetyl
carbinol
2.1-3.2 3-chlorobenzyI 
alcohol
0.6
4-Chlorobenz-
aldehyde
L-4-chloroacetyl
carbinol
6.5-8.0 4-chlorobenzyl
alcohol
0.3
o-Anisaldehyde L-2-methoxyphenyl 
acetyl carbinol
0.8-0.9 2-methoxybenzyl
alcohol
0.9
m-Anisaldehyde L-3-methoxyphenyI 
acetyl carbinol
4.5-5.7 3-methoxybenzyl
alcohol
0.7
p-Anisaldehyde L-4-methoxyphenyI 
acetyl carbinol
1
1.2-3.4
'
4-methoxybenzyl
alcohol
I
0.6
1
Table 2. Yields of carbinol and aromatic alcohol produced by fermentation with Saccharomyces 
cerevisiae
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In the above study gas chromatography was used to determine 
the level of aromatic alcohols produced, and to validate 
the colorimetric method of Groger34 used in the 
determination of L-acetyl aromatic carbinol. Acetylbenzoyl 
(1-phenyl-l,2 propanedione) was used as a standard in both 
of the above methods.
The highest levels of PAC were obtained at benzaldehyde 
concentrations of 6g/L (56mM) and a medium pH of 4.5, while 
yeast dose rates of 60g/L also gave a maximum yield of 
carbinol. In the case of all the aromatic aldehydes 
studied, the production of the corresponding alcohol was 
suppressed when the medium containing sodium pyruvate was 
used. Consequently in these cases the yield of carbinol was 
highest. It was noted in this report that aldehydes having 
substituents in the ortho position of the ring were poor 
substrates for L-acetyl aromatic carbinol production.
In subsequent studies the reaction rates of a number of 
aromatic aldehydes as substrate for Saccharomvces 
cerevisiae were investigated.33 Parameters such as aldehyde 
concentration, medium pH, and yeast dose rate were varied 
and the effect on the level of PAC produced monitored. 
These fermentations were for short periods 
(1 hour) and two mediums were tried. The first contained 
sucrose as the sole carbon source while the second only 
contained sodium pyruvate.
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The benzoin condensation is also a reaction which involves 
an active aldehyde intermediate.35 36 The product is a 
carbinol and is similar to PAC. Thiamine (21) will act as 
a catalyst for the benzoin condensation in an analogous way 
to cyanide 37. The thiazolium zwitterion stabilises the 
active aldehyde intermediate allowing it to react with 
another molecule of benzaldehyde. The reaction has been 
studied extensively as a model for important biochemical 
carbon-carbon bond formation reactions in which the 
catalytic entity is the thiazolium function of thiamine 
pyrophosphate. Some of these pathways are the 
decarboxylation of pyruvic acid to acetoin and the 
transketolase reaction.
During the enzymatic decarboxylation of pyruvic acid the 
thiazolium zwitterion also acts as a catalyst stabilising 
the active aldehyde intermediate, and this intermediate can 
then react further with a molecule of benzaldehyde to 
produce carbinol compound, Scheme 11. In this case the 
active aldehyde is acetaldehyde and the resultant carbinol 
will have the hydroxyl group a to the aromatic ring. The 
enzyme structure is hydrogen bonded to the thiamine complex
22
increasing the basicity of the nitrogen at position 4 on 
the pyrimidine ring. This allows interaction with the 
hydroxyl proton of the a-hydroxyethyl group in the active 
aldehyde which labilises the bond at C-2 and releases the 
product (PAC) from the enzyme complex.
pyruvic acid, and the synthesis of PAC 
from the active aldehyde
23
1.5 REDUCTIVE AMINATION
When aldehydes or ketones are treated with a primary or 
secondary amine in the presence of hydrogen and a 
hydrogenating catalyst, reductive amination of the carbonyl 
compound takes place. The reaction is thought to occur 
through the imine intermediate (22).38
Scheme 12.
Many reagents have been proposed for such a reduction , 
with hydrogen and a metallic catalyst being applied 
commercially. Sodium borohydride, sodium
cyanoborohydride, iron pentacarbonyl and alcoholic KOH, and 
selenophenol ( PhSeH ) have all been successfully applied 
to this reduction.
In a one step reaction from the carbonyl compound the 
reagent selected must be sufficiently inert not to reduce 
the original carbonyl compound before the imine is formed, 
and to reduce the imine in preference to the carbonyl. As
24
mentioned above sodium cyanoborohydride fits such a 
description. The strong electron withdrawing cyano group 
increases the lewis acidity of the corresponding cyano 
borane and the resulting cyanoborohydride anion is more 
reluctant to deliver a hydride. The result is a toned down 
reducing capacity and increased stability which allows more 
discriminative selection among the functional groups.39
The selectivity of the reagent for the reduction of imines 
under acidic conditions was first demonstrated by Kreevoy 
40, who showed that the BH3CN “ anion was stable in acid down 
to pH 3. Further work was carried out by Borch 41 , who
extensively studied the selectivity of this compound as a 
reducing agent in a number of reactions. This selectivity 
was induced solely by altering the pH of the medium. 
Aldehydes and ketones showed optimum reduction using either 
lithium or sodium cyanoborohydride at pH 3-4 in methanol, 
while oximes were reduced to the corresponding 
N-alkylhydroxylamine at pH 4. When it was established that 
the imminium moieties ( >C=N+R2 and >C=N+RH ) were reduced 
with BH 3CN" at pH 6 to 7, and that the reduction of 
ketones was negligible in this range, Borch realised the 
potential of the method to trap the imminium group by 
reduction in the presence of aldehydes and ketones.
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The formation of the imminium moiety is reversible but has 
an optimum at pH 6 (Scheme 13), yet Borch successfully 
exploited the reaction at pH as low as 4 and as high as 10. 
The only requirement was that there was enough proton 
source to generate a positively charged >C=N+< species.
Scheme 13.
The reductive amination of phenylacetyl carbinol has been 
extensively studied by many researchers. This reaction is 
an important step in the synthesis of ephedrine. If the 
reductive amination can be performed stereoselectively 
using (-)-phenylacetyl carbinol as a substrate, then the 
only product formed is the pharmacologically active 
(-)-ephedrine. Some methods of synthesising ephedrine have 
already been discussed in Section 1.3.
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Weichet 18 produced ephedrine by reductive amination of 
(-)-PAC using sodium borohydride and methylamine. He found 
a 4:1 ratio of erythro to threo isomers in the isolated 
product. The method of Hennion and Fleck 42 was applied to 
the synthesis of racemic 3-hydroxy PAC and 4-flouro PAC 
which were used in the synthesis of the corresponding 
ephedrine analogues by the method described above. A 
Czechoslovak patent 43 was later issued to the same authors 
in relation to the synthesis of these compounds by this 
method.
Ose 44 used lithium aluminium hydride as the reductive agent 
in the reductive amination of aryl chlorinated phenylacetyl 
carbinols to produce racemic mixtures of the erythro and 
threo 2-chloro and the 2,4-dichloro ephedrine analogues. 
This work was also the subject of two patents 19,45 and 
included the synthesis of 3,4-dichloroephedrine 
hydrochloride by the action of an acidic solution of KC104 
on ephedrine in the presence of UV light.
27
1.6 DETERMINATION OF ENATIOMERIC PURITY
Only two of the four possible stereoisomers of ephedrine 
have pharmacological activity. These are (1R,2S)(-) 
ephedrine , and (1S,2R) ( + )-iji-ephedrine. When ephedrine is 
prepared from 1-Phenylacetyl carbinol by reductive 
amination, the configuration of carbon-1 is predetermined 
by the stereoselective biotransformation. The reduction 
amination of the carbinol then produces a pair of 
diastereoisomers by introducing another asymétrie centre at 
carbon-2, and their ratio can be determined by quantitative 
high field nuclear magnetic resonance (1H nmr). Alteration 
of the configuration about carbon-1 still remains a 
possibility during this reaction, and this would lead to 
two pairs of enantiomers being formed. The enantiomeric 
excess must now be determined, and by far the most 
succesful method reported was 1H nmr employing chiral 
lanthanide shift reagents.
The study of the structure of ephedrine using 1H nmr was 
first reported by Hyne.46 He prepared oxazolidine, 
spirodecane, and oxazolidone derivatives of (-) ephedrine 
and ( + )-i|;-ephedrine by ring closure across the hydroxyl and 
amino function. He then used 1H nmr to study the influence 
of the phenyl ring on the terminal methyl group as a method 
of detecting the relative spatial distribution of the 
various groups in the molecule.
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Hofer 47 applied chiral relaxation reagents in the 13C nrar 
spectroscopy of ephedrine in order to develop an analytical 
method for determining the enantiomeric purity. He reported 
the formation of diastereomeric complexes from enantiomeric 
ephedrine and the gadolinum relaxation reagent, tris[d,d- 
dicampholymethanate] gadolinum (III) . The difference in 
relaxation time (AAtl) was dramatic, and showed a 
dependence on the concentration of the lanthanide reagent 
used. This decreased rapidly at low concentrations of 
reagent and decreased slowly at higher values. The maximum 
difference ( 0.754 sec) occurred at a concentration of 2.5 
mg of Gd(dcm)3 for the substituted aromatic carbon.
A similar method was applied by Dewar 48, using 1 H nmr on 
a 60 MHz machine. The susceptibility of various groups 
showing sharp lines such as N-CH3 and C-CH3 were 
investigated. Four lanthanide shift reagents were employed, 
the two non chiral reagents were Eu(fod)3 and Pr(fod)3 , 
while the two chiral reagents were Eu(tfc)3 and Pr(tfc)3 . 
The latter gave relatively large differential values (0.33) 
for the C-CH3 doublet in deuterated benzene even though 
line broadening was observed. By using constant shift 
reagent to sample molar ratios, constant instrument 
conditions and a mathematical base line technique, a 
calibration curve giving optical purity was constructed.
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A further study49 also used chiral shift 1H nmr techniques 
to determine the optical purity of ( ± )-ephedrine and ( ± ) —t|r — 
ephedrine. They prepared ephedrine solutions containing the 
europium and prasodynmun derivatives Eu(hfc)3 and Pr(tfc)3 
, and observed the shift of the CH3 doublet. A plot of the 
induced chiral shift against the molecular proportion of 
the lanthanide reagent to substrate was linear at low 
values of the latter. A calibration curve was developed by 
preparing a series of enantiomeric mixtures and plotting 
the theoretical optical purity, determined by polarimetary, 
against the ratio of peak heights of the doublets produced 
by the enantiomers present. Statistical interpretation of 
the results by methods of least squares and analysis of 
variance was applied to the data generated. The agreement 
with the polarimetrie method was within ± 1% .
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1.7 GENERAL PHARMACOLOGY
The autonomic nervous system is divided in two separate 
systems i.e. the Sympathetic and the Parasympathetic 
nervous systems. In the case of the former the 
pregangalonic neuron synapse transmitter is acetylcholine 
and the postgangalonic transmitter is noradrenaline ,but 
acetylcholine is the synapse transmitter in both the pre- 
and postgangalonic neurons in the parasympathetic nervous 
system. As a result of these differences, stimulation of 
either type of nervous system results in opposite 
biological functions.
Activation of the sympathetic system is characterised by 
the release of noradrenaline and the symptoms observed are 
those resulting from the effects of this compound. The 
heart beat rate and blood pressure are raised, the pupils 
and bronchi are dilated, and the liver is stimulated to 
convert glycogen to glucose. It causes the blood to shunt 
from the skin to the muscles, brain, and heart, while 
peristalsis in the intestine and contraction of the bladder 
is inhibited. Overall the effect is one of stimulating the 
body into a highly active state, similar to the effect 
caused by the release of adrenaline into the blood stream 
from the adrenal medulla. Stimulation of the 
parasympathetic nervous system has the opposite effect and 
tends to return the body back to the original deactivated
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state by suppressing the effect of noradrenaline.
Ephedrine is a sympathomimetic amine and falls in the 
category of non-catecholamine drugs as it does not have a 
hydroxyl substituent on the aromatic ring. Ahlquist 50 
suggested that the drugs acted through two cellular 
receptors, a and 3, while Furchgust 51 subdivided these into 
31, 32, al,and a.2 andrenergic receptors. The 31 receptor
has a direct effect on the heart and the 32 effects the 
smooth muscle tissue of the bronchi, uterus, and blood 
vessels. These receptors are believed to be on the cell 
surface and stimulation causes the release of the enzyme 
adenyl cyclase which catalyses the conversion of adenosine 
tri phosphate (ATP) to 3',5'-cyclic adenosine 
monophosphsate (cAMP). It is this secondary cellular 
messenger which is believed to cause the effects observed.
Ephedrine stimulates both the a and 3 andrenergic 
receptors, and the pharmacological effect is described as 
both direct and indirect. The direct effect results from 
stimulation of the above receptors causing increased 
production of cAMP, while the indirect effect is due to
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stimulation of the sympathetic nervous system to release 
noradrenaline, which in turn activates the andrenergic 
receptors.
Ephedrine is used as a nasal decongestant and a 
vasoconstrictor, but unlike adrenaline it is effective by 
the oral route. It is less potent as a bronchodilator but 
has a longer duration of activity than adrenaline, and is 
not metabolised by catechol-o-methyl transferase in the 
blood or monoamine oxidase in the liver. It does however 
undergo deamination and conjugation. The side effects 
during clinical use are tachycardia, hypertension, urinary 
retention, and evidence of CNS stimulation such as nausea 
, vomiting, sweating, vertigo, tremor, and insomnia. As a 
result ephedrine has been largely been replaced by more 
specific 32 stimulators.52
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RESULTS AND DISCUSSION
2.1 FERMENTATION OF AROMATIC ALDEHYDES
The initial experiments were designed to find a method, and 
fermentation medium which gave an appreciable yield of PAC 
or substituted PAC. The mediums used are described in 
Appendix 1 and were initially tried in small batches 
(200 cm3) . The extracted PAC was purified using sodium 
bisulphate method (Section 3.4)
2.1.1 SELECTION OF MEDIUM FOR FERMENTATION
The first medium tried (medium A) was that described by 
Long32. The extraction and purification of the PAC produced 
was carried out according to their method. The yield was 
very low and is given in Table 3. below. This medium 
contained only pyruvic acid as a carbon source for the 
biotransformation.
Because of the low yield the pyruvic acid was replaced with 
sucrose ( medium B ) and the experiment repeated. The yield 
did increase , but was still too low for the later 
reductive amination stage. The medium was further adjusted 
by the addition of a range of minerals. Magnesium ions were 
added and are known to be a necessary co-factor for the 
enzyme involved, and ammonium sulphate was added as a 
source of nitrogen. This corresponded to the medium used by
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Voets 27 and was denoted medium C. Again another increase in 
yield was observed. The final modification was to include 
the minerals from medium C and to add both sucrose and 
pyruvic acid from medium A and B. This medium (medium D) 
gave the highest yields.
MEDIUM YIELD CONCENTRATION
mg/L
Medium A 0.206g 1.03
Medium B 0.301g 1.50
Medium C 0.523g 2.61
Medium D 0.716g 3.58
Table 3. PAC yields from the various mediums tried
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2.1.2 SCALE UP OF FERMENTATION
To produce sufficient PAC for the reductive amination stage 
the scale of the fermentation had to be increased. Medium 
D was selected as the most suitable and a batch size of 800 
cm3 was the maximum which could be handled. The first large 
scale fermentation yielded 1.74g of PAC ( 2.175 g/L ) after 
purification. This yield was not as good as that produced 
under the same conditions using 200 cm3 of medium. To 
improve the air incorporation in the medium, during the 
large scale fermentation, a small pump was used to blow a 
continuous stream of air into the bottom of the vessel. The 
air was dispersed through a narrow nozzle to give a small 
bubble size, and the resulting yield increased to 3.3g 
( 4.12g/L ).
2.1.3 FERMENTATION OF 4-CHLOROBENZALDEHYDE
The production of 4-chloro PAC used the same medium, 
fermentation scale, and extraction method as described 
above in 2.1.2 . The first attempt yielded 0.230g 
(0.25 g/L) and l,5g of the solid aldehyde, which had not 
dissolved, was recovered from the medium. To overcome the 
low solubility of 4-Chlorobenzaldehyde the fermentation was 
repeated but the aldehyde was first dissolved in acetone 
( 10cm3) and the appropriate aliquot added. The yield
increased to 0.6g (0.75 g/L).
36
When the purification was performed in the usual manner 
0.73g of 4-chloro PAC was recovered, however the ether 
washings were retained and when evaporated yielded a 
further 1.8g of the crude compound, which was identified by 
TLC and 1H nuclear magnetic resonance (section 2.1.10) 
This brought the overall yield to approximatly 2.5g
2.1.4 FERMENTATION OF 4-METHOXYBENZALDEHYDE
The 4-methoxybenzaldehyde was fermented using medium D 
(800 cm3). The cells were washed with ethanol and the
washings were returned to the medium before extraction with 
ether, as described in the modified extraction method 
(section 3.3). The aldehyde was added over the seven hour 
period to maintain a concentration of
11 mM . The yield after purification with sodium bisulphate 
was 1.057g ( 1.32g/L ). The fermentation was repeated , but 
the purification step was omitted. The ether extract was 
washed with sodiumcarbonate and evaporated to give a crude 
fraction of 4-methoxy PAC. This crude fraction totalled 
8.13g, which was higher than the reported yield.
37
2.1.5 FERMENTATION OF 2-CHLOROBENZALDEHYDE
The fermentation was carried out using medium D and a batch 
size of 800 cm3. The recovered yeast was in poor condition 
and very dark in colour, which suggests an intolerance of 
the added aldehyde. The modified extraction technique was 
used, and the purification step was omitted. The aldehyde 
was added in aliquots of 1.4 cm3 to give a medium 
concentration of (15 mM) . The extraction yielded 3. 8g of 
viscous yellow liquid, and the 1H nmr results indicated 
that this liquid contained approximately a 50% mixture of 
the parent aldehyde ( 2-chlorobenzaldehyde) and the
corresponding substituted PAC.
2.1.6 FERMENTATION OF 4-METHYLBENZALDEHYDE
4-Methylbenzaldehyde was fermented using medium D 
(800 cm3 ). Six aliquots of 1.3 cm3 of the aldehyde were 
added over the time period and the medium was extracted 
with the revised extraction method (section 3.3). The 
purification step was omitted and 5.134g ( 6.41mg/L) of a 
thick yellow liquid was recovered. This was identified as 
4-methyl PAC by 1H nmr (section 2.1.10), and TLC showed it 
to be sufficiently pure for the reductive amination step.
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4-Fluorobenzaldehyde was fermented and extracted in the 
same manner as described above (Section 3.1.6) . Six
additions of 1.3 cm3 of the aldehyde were made over the 
fermentation period, and 6.7g ( 8.73g/L ) of crude 
4-Fluro PAC was produced. This was recovered as a yellow 
oil
2.1.7 FERMENTATION OF 4-FLUOROBENZALDEHYDE
2.1.8 FERMENTATION OF 3-PYRIDINECARBOXALDEHYDE
The fermentation was preformed as described in section 3.2, 
and the recovered yeast was in good condition. The 
extraction of the medium was carried out as described in 
section 3.3, but only a small quantity (0.3g) of semi solid 
material was recovered. TLC analysis showed this to contain 
a number of different compounds. The 1H nmr data was not 
consistent with that of a carbinol, but showed some 
aldehyde to be present.
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2.1.9 THIN LAYER CHROMATOGRAPHY
The presence of the carbinol compound in the crude 
fermentation extract was confirmerd by TLC, as described in 
section 3.4 . In all cases chloroform was used as the
solvent and the plates were developed with iodine. A good 
resolution of the carbinol was achieved under these 
conditions with the parent aldehyde just below the solvent 
front and the carbinol midway along the plate. The Rf 
values of the compounds mentioned above 
are given in Table 4.
CARBINOL COMPOUND Rf
VALUE
PARENT ALDEHYDE 
Rf VALUE
(-)PHENYLACETYL CARBINOL 
(PAC)
0.47 0.83
(-)-4-CHLORO PAC 0.48 0.83
(-)-4-METHOXY PAC 0.41 0. 79
(-)-4-METHYL PAC 0.45 0.73
(-)-4-FLUORO PAC 0 . 43 0 . 79
(-)-2-CHLORO PAC 0.45 0.85
Table 4. Rf vales of aromatic substituted PAC and 
parent aldehyde
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During the fermentation of 4-methoxybenzaldehyde, the TLC 
plate of the crude extract was compared to that of the 
purified extract. The latter showed a higher concentration 
of parent aldehyde than the crude extract. This seems to 
suggest that during the bisulphate purification step the 
parent aldehyde is extracted as efficiently as the carbinol 
compound. This step does not have any significant benefit 
in preparing the carbinol for the reductive amination 
reaction.
Column chromatography was performed on the crude extract 
from the fermentation of benzaldehyde and 
4-chlorobenzaldehyde, by the method described in 
section 3.6 , using chloroform as the eluant. In each case 
the carbinol was identified as the largest band present and 
followed a small yellow band. It was well resolved from all 
the other compounds present, and was recovered as a thick 
yellow oil in the case of PAC and as a yellow semi-solid in 
the case of 4-chloro PAC.
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2.1.10 nH NMR OF THE FERMENTATION EXTRACTS
The nrar data were recorded on the Perkin Elmer R-12B 60 MHz 
machine as described in section 3.10. The data was recorded 
on the neat compound in some cases.
1H NMR OF PHENYLACETYL CARBINOL 
1H NMR ( ppm, CDC13 )
The sample had been passed through a chromatography column 
prior to recording the data.
2.02 ppm ( 3H,s, CH-CH3 )
5.05 ppm (1H,s,C-OH) 
see appendix II
1H NMR OF 4-CHLORO PHENYLACETYL CARBINOL
1H NMR ( ppm, CDC13 )
The sample had been passed through a chromatography column 
prior to recording the data.
2.02 ppm ( 3H,s, CH-CH3 ) 4.3 ppm (lH,s,CH-OH )
5.10 ppm (1H,s,C-OH) 7.30 ppm ( 5H,s, ArH )
4.40 ppm (1H,s,CH-OH ) 
7.30 ppm ( 5H,s, ArH )
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1H NMR OF 4-METHOXY PHENYLACETYL CARBINOL
1H NMR ( ppm, CDCl, )
The sample was extracted from the fermentation medium and 
purified using sodium bisulphate( section 3.4)
2.05 ppm ( 3H,s, CH-CH3 ) 3.75 ppm ( 3H,s, ArOCH3 )
4.5 ppm (lH,s,CH-OH ) 5.10 ppm (lH,s,C-OH)
6.7-7.4 ppm ( 4H,M, ArH )
^  NMR OF 4-METHYL PHENYLACETYL CARBINOL 
1H NMR ( ppm, neat )
The sample was extracted from the fermentation medium.
1.4 ppm ( 3H,s, CH-CH3 ) 1.65 ppm ( 3H,s,Ar-CH3 )
4.05 ppm (1H,S,CH-OH ) 4.6 ppm (1H,S,C-0H)
6.3-6.9 ppm ( 4H,m, ArH )
The peak at 4.05 ppm showed a broad shoulder on the
downfield side.
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1H NMR OF 4-FLUORO PHENYLACETYL CARBINOL
1H NMR ( ppm, neat )
The sample was extracted from the fermentation medium.
1.5 ppm ( 3H,s, CH-CH3 ) 4.05 ppm (lH,s,CH-OH )
4.06 ppm (1H,s,C-OH) 6.2-7.0 ppm ( 5H,s, ArH )
9.3 ppm ( trace of parent aldehyde)
2.1.11 APPRAISAL OF RESULTS
The results indicate the viability of a fermentation method 
for the production of substituted PAC compounds with the 
exception of 2-chlorobenzaldehyde and
3-pyridinecarboxaldehyde, which are not good substrates for 
this biotransformation. The purification step described by 
Long32 has been shown not to be a necessary step prior to 
the reductive amination and was omitted during further 
work.
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2.2 REDUCTIVE AMINATION AND PREPARATION OF EPHEDRINE
ANALOGUES
2.2.1 REDUCTIVE AMINATION OF ACETOPHENONE
Borch41 carried out a reductive amination on acetophenone 
using sodium cyanoborohydride and methylamine in absolute 
methanol at pH 6 - 8. The reported yields of 
N-methylphenethylamine were 78% and the melting point of 
the hydrochloride derivative was 178°-178°C. In this 
researchthe reaction was performed replacing methylamine 
free base by the hydrochloride derivative (section 3.7). In 
both runs of this reaction 20mM of acetophenpone were used 
and the yields of crude products were 1.35g and 1.43g 
respectively. The product was recovered as a thick viscous 
oil which was slightly yellow in colour.
1H NMR (neat)
1.4ppm ( 3H,s ,C-CH3 )
2.3ppm ( 3H,s, N-CH3 )
7.4ppm ( 5H,S,ArH )
The hydrochloride derivative was prepared by the method 
described in section 3.8, to give sticky white solid. It 
was recrystallised from petroleum ether/methanol to give 
white waxy solid with a melting point range 
159.1°-165.3°C. Two subsequent recrystallisations from
1.7ppm ( 3H,s,N-H )
3.7ppm (lH,m,CH-OH )
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carbon tetrachloride / chloroform yielded a similar white 
solid with a melting point of 172.8°-173.4°C.
These results indicate that the reductive amination of 
crowded ketones can be prepared using methylamine 
hydrochloride as a replacement for the methanolic solution 
of methylamine used by Borch38. The yield were lower, and in 
the order of 25% .
2.2.2 SYNTHESIS OF EPHEDRINE
The reductive amination of PAC was carried out as described 
in section 3.7. In two sequential reactions 0.4g and 1.86g 
of PAC yielded 0.34g and 0.91g of crude ephedrine 
respectively. This product was a viscous yellow oil which 
contained a waxy white solid. These yields represent a 
mixture of the two isomers, the oil being the i|r-ephedrine 
and the solid being ephedrine which has a higher melting 
point. The presence of the ephedrine isomers were 
confirmed by 1H nmr.
1H NMR of crude ephedrine free base ( ppm CDC13 )
0.9ppm ( 3H,s,CH-CH3 ) 2.4ppm (3H,s, N-CH3 )
2.5-3.0 (m,not assigned) 4.7ppm (lH,d, CH-OH )
7.3ppm ( 5H,s,ArH )
This recorded spectrum was identical to that available in 
the reference literature 51
46
PREPARATION OF THE HYDROCHLORIDE DERIVATIVE
The hydrochloride was initially prepared by dissolving the 
crude ephedrine mixture in methanol and adding concentrated 
hydrochloric acid. The yield from this method was as low as 
10%, and the acidity may have caused the ephedrine to 
decompose back to the original PAC and methylamine. A 
modified method using hydrogenchloride gas was developed 
and used in all subsequent preparations (section 3.8).
FRACTIONAL CRYSTALLISATION OF EPHEDRINE 
HYDROCHLORIDE MIXTURE
The isomers were crudely separated from the oily matrix in 
which it was recovered, using cold acetone. The ephedrine 
fraction is insoluble in this solvent and separates as a 
waxy white solid. The ephedrine isomer is only slightly 
soluble in hot chloroform, while the i|i-isomer is fully 
soluble . This property was exploited to crudely separate 
the two isomers, the ephedrine fraction being recovered 
with a higher purity.
RECRYSTALLISATION OF THE EPHEDRINE FRACTION
The hydrochloride fraction was recrystallised twice from 
acetone/methanol (15:1) to give white needles with a 
melting point range of 215.5°-216.3°C
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MICROANALYSIS OF EPHEDRINE HYDROCHLORIDE
THEORY MEASURED
CARBON 59.55% 59.07%
HYDROGEN 7.94% 8.02%
NITROGEN 6.72% 6.94%
OPTICAL POLARIMETRY OF EPHEDRINE HYDROCHLORIDE
The optical rotation of the compound was measured using 
deionised water as a solvent (section 3.10). The small 
quantity of pure compound available made it necessary for 
concentrated solutions to be used, and a short path length 
cell was employed. The optical rotation is concentration 
dependent and as no literature values were available at the 
concentrations used the commercial (-)ephedrine 
hydrochloride was employed as a standard.
SYNTHETIC EPHEDRINE HYDROCHLORIDE.
[o]0 - 24.28° H 20 C = 28.5
COMMERCIAL (-) EPHEDRINE HYDROCHLORIDE
[a]D - 25.9° H 20 C = 27.0
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This fraction was recovered by evaporating the chloroform 
used to separate the ephedrine hydrochloride. It was 
recrystallised twice from carbon tetrachloroide / 
chloroform mixture (10:2) to give a white crystalline 
solid with a melting point range of 160.3° - 162.6°C .
1H NMR Of ill-EPHEDRINE HYDROCHLORIDE
RECRYSTALLISATION OF THE fr-EPHEDRINE FRACTION
1H NMR ( ppm D20 )
l.lppm ( 3H,d,CH-CH3 )
3.3-3.8ppm (not assigned ) 
7.5ppm ( 5H,s,ArH )
2.8ppm ( 3H,s,N-CH3 ) 
4. 5ppm ( H20 in D20 )
MICROANALYSIS OF ^-EPHEDRINE HYDROCHLORIDE
THEORY MEASURED
CARBON 59.55% 59.36%
HYDROGEN 7.94% 7.84%
NITROGEN 6.72% 6.64%
OPTICAL POLARIMETRY OF EPHEDRINE HYDROCHLORIDE
The optical rotation of the ijr-ephedrine hydrochloride was 
measured using the described method ( Section 3.10 ).
[a]D - 33.77° h2o C = 26.4
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APPRAISAL OF RESULTS
The analytical results on the (-)-ephedrine hydrochloride 
isolated suggest that the sample was optically pure and 
that it had been successfully separated from the pseudo 
isomer. The (-) -i|j-ephedrine hydrochloride had a lower 
melting point than that quoted in the literature 
suggesting that some of the erythro isomer still remained 
despite the repeated recrystallisations. Evidence to 
suggest this was also observed during the pharmacological 
experiments (Section 2.4).
2.2.3 SYNTHESIS OF 4-CHLOROEPHEDRINE
The reductive amination of 4-chloro PAC was carried out as 
described in section 3.7. The product was recovered as a 
semi solid yellow oil which solidified on cooling below 
room temperature. The hydrochloride derivative was prepared 
and recovered as a waxy cream coloured solid, with an 
overall yield in the order of 10 to 15%.
SEPARATION OF ISOMER MIXTURE
The 4-chloroephedrine hydrochloride isomers were washed 
with cold acetone to remove the oily matrix in which they 
were recovered. The erythro isomer was crudely separated 
from the pseudo isomer using hot chloroform, the later 
being very soluble in this solvent. The former was 
recovered as a gritty white solid with a melting point of 
243.6° - 244.1°C .
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RECRYSTALLISATION OF 4-CHLOROEPHEDRINE
HYDROCHLORIDE
The crude 4-chloroephedrine described above was 
recrystallised twice from a mixture of acetone and methanol 
(17:3) to give large clear crystal needles which had a 
sharp melting point 244.5°- 245.0°C .
1H NMR OF 4-CHLOROEPHEDRINE HYDROCHLORIDE 
1H NMR ( ppm, D20 )
1.25 ppm ( 3H,s, CH-CH3 ) 2.9 ppm ( 3H,s, N-CH3 )
5.25 ppm (lH,m, not assigned ) 7.55 ppm (4H,s, ArH )
MICROANALYSIS OF 4-CHLOROEPHEDRINE HYDROCHLORIDE
THEORY MEASURED
CARBON 50.85% 50.83%
HYDROGEN 6.36% 6.57%
NITROGEN 5.93% 5.82%
OPTICAL POLARIMETRY OF 4-CHLOROEPHEDRINE 
HYDROCHLORIDE
The optical polarimetry of 4-chloroephedrine hydrochloride 
was carried out as described in section 3.10. The 
solubility of this compound in water was much less than 
that of ephedrine, consequently the observed rotation using 
the 0.1 mL cell was very low. The measurement was repeated 
using a larger cell and the results are given below.
0.1 mL cell [cr]D -33.22° H20 C = 6.0
1.0 mL cell [a]D -31.11° H20 C = 4.5
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The pseudo isomer was recrystallised from a carbon 
tetrachloride / chloroform mixture ( 4:1 ) to give white
solid (47 mg) with a melting point of 144.2°- 146°C. The 
crystals differed to that observed for the 4- 
chloroephedrine isomer.
1H NMR OF ilr-4-CHLOROEPHEDRINE HYDROCHLORIDE 
1H NMR ( ppm, D20 )
1.2 0 ppm ( 3H,d, CH-CH3 ) 2.85 ppm ( 3H,s, N-CH3 )
4.3 ppm (lH,M,not assigned ) 7.45 ppm (4H,s, ArH )
OPTICAL POLARIMETRY OF ft-4-CHLOROEPHEDRINE 
HYDROCHLORIDE
Because the 4-chloroephedrine hydrochloride was not very 
soluble in water , dilute HCl ( 5M ) was selected as a 
solvent for the pseudo isomer. The compound was however 
very soluble in this solvent, and the optical rotation was 
measured at a low concentration using the 0.1 mL cell.
[a]D -31.8° HCl 5M C = 6.0
RECRYSTALLISATION OF *-4-CHLOROEPHEDRINE
HYDROCHLORIDE
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The 4-chloroephedrine hydrochloride was easily recovered in 
the form of large pure crystals which were produced in 
sufficient quantity for further investigation. The melting 
point recorded was in the same range as the values 
published44 , 245°-6°C. The 1H nmr data was in agreement with 
that expected for the structure, and the microanalysis data 
agreed with the theoretical values. Although no literature 
values were available for the optical rotation of this 
isomer, the observed values were of the correct direction.
The i)j-4-chloroephedrine hydrochloride was more difficult to 
recrystallised than the isomer described above, and the 
yields were consequently much lower. No literature melting 
point, or optical rotation values were available for this 
compound.
APPRAISAL OF RESULTS
2.2.4 SYNTHESIS OF 4-METHOXYEPHEDRINE
The reductive amination of 4-methoxy PAC was carried out as 
described in section 3.7. The isomeric mixture was 
recovered as a yellow oil. The hydrochloride derivative was 
prepared by passing hydrogen chloride gas through a 
solution of the compound (section 3.8) and the crude 
product was recovered as a waxy solid which had a slight 
yellow coloured.
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The crude mixture of isomers were separated from the oily 
material by washing with cold acetone. The resulting white 
solid was washed with hot chloroform to remove the 
(1R,2R)-i|i-isoraer, and the insoluble crude material had a 
melting point of 199°-204°C. The chloroform washings were 
evaporated but did not yield the ijr-isomer, and consequently 
the acetone washings of the original crude material were 
retained and examined. This yielded a small quantity of 
white solid on evaporation of some of the solvent. This 
crude compound had a melting point range of 160°-166°C
RECRYSTALLISATION OF 4-METHOXYEPHEDRINE 
HYDROCHLORIDE
The 4-methoxyephedrine hydrochloride was recrystallised 
from a chloroform / methanol ( 20:1 ) mixture to give a 
fine white crystalline solid. This was further 
recrystallised from acetone / methanol ( 20:1 ) mixture
until a constant melting point was obtained( 236°-239°C)
1H NMR OF 4-METHOXYEPHEDRINE HYDROCHLORIDE 
1H NMR ( ppm, D20 )
1.1 - 1.25ppm ( 3H,d, CH-CH3 ) 2.8 ppm ( 3H,s, N-CH3 )
3.85ppm ( 311,6, OCH3 ) 5.1 ppm (lH,M,not assigned)
6.9 - 7.6 ppm(4H,s, ArH ) see appendix II
SEPARATION OF ISOMER MIXTURE
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MICROANALYSIS OF 4-METHOXYEPHEDRINE HYDROCHLORIDE
THEORY MEASURED
CARBON 57.02% 56.86%
HYDROGEN 7 .78% 7.64%
NITROGEN 6.05% 5.97%
OPTICAL POLARIMETRY OF 4-METHOXYEPHEDRINE 
HYDROCHLORIDE
The optical rotation of this compound was measured as 
described in section 3.10. The compound was only slightly 
soluble in water and the measurement was recorded using a
1.0 ml cell
EXAMINATION OF " tt-4-METHOXYEPHEDRINE "
HYDROCHLORIDE
The hydrochloride fraction recovered from the acetone 
washings above, was recrystallised from ethanol to give 
clear cubic crystals with a melting point of 167°-168°C. 
This compound had no optical rotation, and the 1H nmr data 
was not consistent with that expected from i|i-4- 
methoxyephedrine.
t«]0 -29.3° H20 C = 4.75
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2.4 ppm ( 3H,s, N-CH3 )
3.85 ppm ( 2H,s, Ar-CH2-N )
1H NMR ( ppm, D20 )
3.51 ppm ( 3H,s, OCH3 )
6.6 - 7.3 ppm(4H,m, ArH )
The characteristic doublet between 1-2 ppm resulting from 
the methyl group is not present, and the methine multiplet 
at 4.8 - 5.5 ppm resulting from the proton a to the 
aromatic ring is also missing. These have been replaced by 
a new peak at 3.85 ppm which integrates for two protons. 
This suggests that the compound is the product of the 
reductive amination of 4-methoxy PAC . This was confirmed 
by synthesis.
REDUCTIVE AMINATION OF 4-METHOXYBEWZALDEHYDE
A reductive amination was preformed on
4-methoxybenzaldehyde as described in section 3.7. The 
hydrochloride derivative of the resulting yellow oil was 
prepared as according to Section 3.8, and the white solid 
produced was washed with acetone prior to recrystallisation 
from ethanol. The product was recovered as white cubic 
crystals similar to those described above. The melting 
point was recorded as 167°-168°C and the 1H nmr data for 
this compound was idenyical to the product described from 
the attempt to synthesise i|r-4-methoxyephedrine.
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APPRAISAL OF RESULTS
No literature data was found on any of the possible isomers 
of 4-methoxyephedrine. The microanalysis data and the 1H nmr 
results suggest that the synthesised compound has the 
correct structure, and the sharp melting point suggests 
that it is quite pure. The optical rotation is of the 
correct direction but this cannot confirm the optical 
purity of the compound. The i|i-4-methoxyephedrine analog was 
not found during the synthesis, but the reductive amination 
product of 4-methoxybenzaldehyde was detected.
2.2.5 SYNTHESIS OF 4-METHYLEPHEDRINE
The 4-methyl PAC produced by fermentation was reduced in 
the presence of methylamine hydrochloride to give the 
methyl substituted ephedrine analogue (section 3.7). This 
was recovered as a thick, yellow oil, and the hydrochloride 
derivative was prepared. It was recovered as a white solid 
in a yellow oily matrix.
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The hydrochloride mixture was washed with acetone to give 
a white solid and yellow acetone washing. These were 
concentrated by evaporation of the solvent and a further 
yield of the white solid was recovered by the addition of 
diethyl ether. The two fractions were combined, but the 
isomers could not be separated using hot chloroform as 
described in previous sections, as the compound was very 
soluble in this solvent. Hot acetone was used and the 
insoluble fraction recovered as a white solid with a 
melting point 212°-225°C. The acetone soluble fraction was 
recovered by evaporation to give a white solid with a 
melting point of 131.2°-138.7°C .
SEPARATION OF ISOMER MIXTURE
RECRYSTALLISATION OF 4-METHYLEPHEDRINE 
HYDROCHLORIDE
The crude 4-methylephedrine hydrochloride was dissolved in 
a 50/50 acetone/chloroform mixture by heating and adding 
methanol dropwise. The compound recrystallised from this 
solvent mixture to give 134mg of white powder with a 
melting point of 220°-222°C .
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MICROANALYSIS OF 4-METHYLEPHEDRINE HYDROCHLORIDE
THEORY MEASURED
CARBON 61 .52% 61.56%
HYDROGEN 8.35% 8.57%
NITROGEN 6.50% 6.38%
OPTICAL POLARIMETRY OF 4-METHYLEPHEDRINE 
HYDROCHLORIDE
The optical rotation was measured according to section 
3.10, and as the compound has a good solubility in water 
only a small quantity of concentrated solution was prepared 
which gave an easily detectable rotation in the 0.lmL cell.
2.2.6 SYNTHESIS OF 4-FLUOROEPHEDRINE
The reductive amination of 4-fluoro PAC was carried out as 
described in section 3.7, to yield a thick yellow oil. This 
oil was dissolved in diethyl ether and when the volume of 
solvent was reduced a white solid precipitate was formed 
leaving a yellow solution. This solid was recrystallised 
from the same solvent to give large cubic crystals of 
fluoroephedrine (0.34g), with a melting point of 133.5°- 
135°C. The yellow solution described above was evaporated 
to give a thick oil, and the hydrochloride derivative of 
this compound was prepared as described in section 3.8, 
producing a white solid.
[a]„ -30.70° H20 C = 13.0
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SEPARATION OF ISOMER MIXTURE
The isomers were readily separated at this stage as the 
threo isomer was only sparingly soluble in diethyl ether 
and was precipitated as the free base .
RECRYSTALLISATION OF 4-FLUOROEPHEDRINE 
HYDROCHLORIDE
The hydrochloride was insoluble in hot chloroform but was 
recrystallised from a 50/50 acetone chloroform mixture to 
give a white powder ( 58mg), with a melting point 195°-
19 7 °C
MICROANALYSIS OF 4-FLUOROEPHEDRINE HYDROCHLORIDE
THEORY MEASURED
CARBON 54.67% 54.84%
HYDROGEN 6.83% 7.06%
NITROGEN 6.38% 6 .22%
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OPTICAL POLARIMETRY OF 4-FLUOROEPHEDRINE
HYDROCHLORIDE
The optical rotation of the erythro isomer was measured as 
described in section 3.10, using a 0.lmL cell.
0.1 mL cell [a]D -25.06° H20 C = 20.0
PREPARATION OF THE HYDROCHLORIDE DERIVATIVE OF 
*-4-FLUOROEPHEDRINE
A solution of the ty-4-fluoroephedrine free base in diethyl 
ether / chloroform ( 60:40 ) was treated with hydrochloride 
gas. The resulting hydrochloride was fully soluble in this 
solvent, and the compound was recovered by rotary 
evaporation to yield a sticky white solid. This was washed 
with cold acetone to give the crude hydrochloride 
derivative.
RECRYSTALLISATION OF ^-4-FLUOROEPHEDRINE 
HYDROCHLORIDE
The hydrochloride derivative of i|r-4-fluoroephedrine was 
recrystallised from chloroform to give a white powder 
(140 mg) with a melting point of 169.8°-170.4°C .
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1H NMR OF É-4-FLUOROEPHEDRINE FREE BASE
1H NMR ( ppm, CDCI3 )
0.95-1.0 ppm ( 3H,d, CH-CH3 ) 2.45 ppm ( 3H,s, N-CH3 )
4.1-4.25 (lH,d,not assigned) 6 .9-7.5 ppm (4H,m, ArH )
The peak at 2.45 ppm had a small shoulder extending 
downfield to 2.9 ppm .
1H NMR OF ib-4-FLUOROEPHEDRINE HYDROCHLORIDE 
1H NMR ( ppm, D20? )
0.95-1.1 ppm ( 3H,d, CH-CH3 ) 2.7 ppm ( 3H,s, N-CH3 )
5.05 ppm (lH,m,not assigned ) 6.9-7.5 ppm (4H,s, ArH )
OPTICAL POLARIMETRY OF »-4-FLUOROEPHEDRINE 
HYDROCHLORIDE
The optical rotation was measured as described in section
3.10 , using a 0.lmL cell.
[a ]D -47.15° H20 C = 21.2
APPRAISAL OF RESULTS
The synthesis of para fluoroephedrine differed from the 
other synthesis in that the (-)-i|i-4-fluoroephedrine free 
base was easily separated from the erythro isomer after the
62
reductive amination step. The melting point recorded for 
this free base is higher than that reported in the 
literature 18, where the published value was 114°C for a 
racemic mixture. However the melting point for the 
hydrochloride derivative of this isomer did agree with the 
reported value of 170°C by the same author.
The ’h nmr data for the two hydrochloride derivatives, and 
the ijj-free base, are in agreement with that expected for 
their structures, and the microanalysis results also agreed 
well with the theoretical values. The melting point 
recorded for the (-)-4-fluoroephedrine was lower than that 
reported by Weichet 18, and also lower than that reported 
earlier by Kraft and Dengel,( 222°C )15. This suggests that 
the erythro compound may still contain a trace of the 
ijr-isomer even after repeated recrystallisations. The 
optical rotation value cannot be used to resolve this 
matter as the are no literature values for comparison.
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2.3 HIGH FIELD 1H NMR STUDIES
The high field nmr data was collected using a Bruker AC 
400, 400 MHz instrument as described in section 3.10.4 , 
and the chiral shift studies were preformed using Pr(tfc)3 
in deuterated chloroform.
High field nmr study of PAC
The crude PAC extract was passed through a chromatography 
column as described in section 3.6 , and a sample (20 mg) 
was dissolved in deuterated chloroform (0.5 ml) and placed 
in an nmr tube (5mm). The singlet due to the C-CH3 and N-CH3 
was observed at 2.09 ppm and 4.7ppm respectively. Pr(tfc)3 
(lmg) was added and these bands were shifted upfield to 
1.95ppm and 4.48ppm , no splitting of the bands were
observed. Addition of another lmg of shift reagent caused 
a complete collapse of the signal due to line broadening. 
This suggests that the biotransformation is indeed 
stereoselective at carbon 1 and that the molar ratio of 
compound to shift reagent for optimum resolution lies 
between 1 : 0.0042 and 1 : 0.0128
High field nmr of racemic synthetic ephedrine
The nmr spectrum of the mixture produced by the reductive 
amination of PAC suggested the presence of a pair of 
diastereoisomers, (-) ephedrine and (-)-i)i-ephedrine. It
showed a doublet at 0.75-0.83ppm due to C-CH3 and on close 
inspection each band was further split into two bands.
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The characteristic N-CH3 band at 2.35ppm could also be seen 
to be split into a doublet, and the relative hight of these 
bands indicated that the (-) ephedrine/ (-)-ijr-ephedrine 
ratio was approximately 65/35, (Figure 6 ,appendix II) .
As these compounds were collected after the reductive 
amination step the results seem to suggest only slight 
degree of stereoselectivity in this reaction.
High field nmr of (-)ephedrine
The (-) ephedrine fraction of the racemate described above 
was separated by fractional crystallisation of the 
hydrochloride derivative as described in section 3.9 . This 
hydrochloride was converted back to the free base prior to 
the nmr studies. The spectrum observed was identical to 
that observed with the commercial (1R,2S)-ephedrine 
purchased from Aldrich chemicals,( Figure 7 and 8 Appendix 
II). Chiral Pr(tfc)3 (lmg) was added to a 2M solution of 
synthetic (-) ephedrine in CDC13 the N-CH3 band at 2.37ppm 
collapsed completely into a broad hump. The C-CH3 doublet at 
0.7 6ppm was shifted upfield to 0.7 4ppm but retained the 
same JJ coupling (6Hz). Two further additions of lmg of 
shift reagent moved the band upfield to 0.7ppm, but they 
remained clearly defined as a doublet. The presence of 
anything but minute quantities of the (+) ephedrine isomer 
can thus be ruled out, and suggests that the configuration 
about carbon 1 does not alter during the synthesis.
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High field nmr of enantiomeric mixture of ephedrine
During the studies described above the use of chiral 
Pr(tfc)3 under the conditions stated did not indicate the 
presence of any enantiomeric mixtures. For this to be 
acceptable as evidence of their absence racemic mixtures of 
commercial (-) and ( + ) ephedrine were prepared. This was 
dissolved in deuterated chloroform to give a 2M solution. 
The nmr tube (5mm) was loaded with this solution (0.5ml) 
and the spectrum recorded as described in section 3.10.4 . 
The chiral shift reagent (lmg) was added and the data 
collected again. The N-CH3 peak collapsed and the C-CH3 
doublet at 0.7 6ppm was shifted upfield to 0.7ppm . Two 
distinct doublets were apparent with the two enantiomers 
separating by about 6.2Hz . Two more additions of the
chiral shift reagent (0.5mg) caused the peaks to shift 
further upfield and increased the resolution of the 
enantiomers, before the bands became excessively broad, 
(Figure 9. Appendix II). This indicates the effectiveness 
of this reagent and conditions for resolving ephedrine 
enantiomers and the absence of band splitting indicates 
enantiomeric purity in the compounds described.
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2.4 PHARMACOLOGICAL STUDY OF THE EPHEDRINE
ANALOGUES
The measurement of antispasmodic activity in the 
synthesised ephedrine analogues was attempted on tissue 
section which were stored overnight in thyroid solution at 
5°C . The spasms observed from this tissue were very
variable , and a constant base line could not be obtained 
for comparison. The recovery of the tissue after addition 
of ephedrine was prolonged and no reasonable measurements 
were obtained.
The experiments were repeated using fresh tissue . The 
observed spasms were stronger and faster, with a constant 
base line, and recovered faster after washing. The 
experimental conditions and procedures are described in 
Section 3.11 .
The observed reduction in the length of the spasm trace was 
expressed as a percentage of the original trace length and 
the results are given in Table 5.
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COMPOUND NAME R S 
CONFIG.
SOLUTION
MOLARITY
%
SUPRESSI0N
%
SUPRESSI0N
%
SUPRESSI0N
Commercial (-)ephedrine HCl 1R2S 0.0003M 77% 79% 87%
Synthetic (-)ephedrine HCl 1R2S 0.0003M 80% 80% -
Commercial (-)-f-ephedrine HCl 1R2R 0.0003M 0% 0% 0%
Synthetic (-)-f-ephedrine HCl 1R2S 0.0003M 14% - -
Commercial (+)-if-ephedrine HCl 1S2S 0.0003M 35% 43% 28%
Synthetic C-)-4-fluoroephedrine 
HCl
1R2S 0.0003M 92% 94% 96%
Synthetis (-)-iJ-4-fIuoroephedrine
HCl
1R2R 0.0003M 0% 0% -
Synthetic(-)-4-methylephedrine
HCL
1R2S 0.0003M 83% 81% 83%
Synthet i c(-)-4-methoxyephedri ne 
HCl
1R2S 0.0003M 17% 18% -
Synthetic(-)-4-chloroephedrine 
HCl
1R2S 0.0003M >100% >100% >100%
Commercial (-)ephedrine HCl 1R2S 0.0001M 40% - -
Synthetic (-)-4-chloroephedrine 
HCl
1R2S 0.0001M 80% - -
Synthetic (-)-4-fluoroephedrine 
HCL
1R2S 0.0001M 29% ~ “
Table 5. Observed antispasmodic activity of the synthesised compounds and commercial references. 
See appendix III
In most cases the compounds were tried on three pieces of 
tissue. Commercial ephedrine hydrochloride isomers were used 
as control compounds , and as expected only the (-) ephedrine 
and the ( + )-ip-ephedrine hydrochloride had any activity. The 
synthesised (-) ephedrine hydrochloride showed very similar 
activity to the corresponding commercial control, but the 
synthesised ( - )-i{i-ephedrine hydrochloride showed a small level
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of activity which was not expected. This suggests that the 
compound may still contain a small trace of the erythro 
isomer.
The (-)-4-fluoro and the (-)-4-methylephedrine 
hydrochloride analogues also showed similar activity to the 
control (-)-ephedrine compound, but the synthesised (-)-4- 
chloroephedrine hydrochloride showed a greater suppression 
of the tissue spasms. The (-)-4-methoxy analogue showed 
very little activity and the
(- )-i)r-4-f luoroephedrine isomer showed no activity.
A comparison of the commercial (-)-ephedrine and the 
corresponding 4-chloro and 4-fluoro analogues at lower 
dosage also showed the (-)-4-chloroephedrine hydrochloride 
to have a higher activity than the control compound.
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2.5 DISCUSSION
The production of phenyl acetyl carbinol by fermentative 
techniques has been extensively applied to the commercial 
synthesis of ephedrine. The complete stereospecificity of 
the enzyme catalysed reaction being the major attribute. 
Much work has already been undertaken to maximise the yield 
of phenyl acetyl carbinol produced, and during this 
research small changes were made to the methods already 
published which resulted in sufficiently high yields for 
the second step of the synthesis pathway to be possible. 
The fermentation method used here is not commercially 
viable due to the cost of the medium.
While some publications mentioned the possibility of novel 
carbinol compounds being produced by employing substituted 
benzaldehyde as a substrate for the fermentation, very 
little work seems to have been published on this matter. 
Long32,33 demonstrated the usefulness of this technique on a 
range of substituted aldehydes and indicated the potential 
yields based on quantitative analytical methods. In this 
report some of the aldehydes previously used were fermented 
and again the extracted carbinols were produced in 
sufficiently high yields to allow subsequent reductive 
amination. No attempt was made to maximise the yields in 
these cases, but adjustment of the medium aldehyde 
concentrations during the fermentation and comparing this
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to the subsequent carbinol yield, would give information of 
the correct dosage for each of the substituted aldehydes. 
4-chlorobenzaldehyde was the only solid aldehyde used, and 
it was found to be only sparingly soluble in the aqueous 
medium. Dissolving the compound in acetone prior to 
addition to the fermentation medium was found to be far 
more productive, giving extracted yield at the upper range 
of that measured by Long32.
3-Pyridinecarboxaldehyde had not previously been fermented 
by other research workers, and yet it seemed an ideal 
substrate due to its high solubility in water. When this 
biotransformation was attempted no parent aldehyde or 
pyridal carbinol were recovered in the medium extract. One 
possible explanation is that the carbinol would also be 
highly soluble in water and would not be removed during the 
ether extraction.
The fermentation of 2-chlorobenzaldehyde gave a crude 
extract which contained a high quantity of parent aldehyde 
mixed with the substituted PAC. the reductive amination of 
this compound was a not attempted for this reason. Long 
also observed a low biotransformation for this aldehyde. 
The fermentation of 4-methoxybenzaldehyde however gave a 
higher crude yield than that reported by Long.
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The purification of the carbinol by extracting with sodium 
bisulphate was used in the initial stages of the research. 
The yields of 'purified' compound were only in the order of 
10% to 20% of the original crude extract, and were found to 
contain a higher proportion of parent aldehyde than the 
extract. For this reason the purification step was omitted 
in further work.
Column chromatography was carried out on the crude PAC 
extract as a means of purification but the yields were so 
small that its use became questionable. This was further 
amplified when the reductive amination step of the purified 
compound yielded a product which still required a number of 
recrystallisation steps before a pure compound could be 
reached. It was then decided to use the crude extract as a 
starting point for the reductive amination and to purify 
the compounds at a later stage.
The reductive amination of the substituted carbinols was 
based on the method of Borch41, using sodium 
cyanoborohydride as a selective reducing agent by 
controlling the solution pH. Methylamine was replaced with 
the hydrochloride derivative and acetophenone was used as 
a trial compound. The results compared well with the data 
published by Borch indicating a successful synthesis.
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When this method was applied to PAC, ephedrine and 
f-ephedrine were produced. An accurate yield can not be 
calculated because the starting compound may contain some 
benzyl alcohol, and the number of recrystallisation steps 
resulted in considerable loss of compound. Consequently 
any method of estimating the stereoselectivity of the 
reaction based on the weight of the diastereoisomers 
produced cannot be applied. This may however be possible 
using high field nmr or chiral high performance liquid 
chromatography.
In the case of the substituted PAC the reductive amination 
produced the corresponding ephedrine analogue as a mixture 
of isomers. It was very difficult to obtain the \|i—4 — 
methylephedrine hydrochloride in a pure form, due to the 
similar solubility of the erythro isomer. Consequently very 
little data was collected on this compound. The reductive 
amination of 4-methoxy PAC did not seem to yield any threo 
isomer. Its presence may have been missed due to the 
production of side products, or if it was highly soluble in 
acetone it may have been removed completely by the initial 
washing.
The hydrochloride derivative was prepared for each compound 
synthesised. In all cases the compounds were recovered as 
a sticky solid in a oily matrix. This even occurred when 
pure commercial i|f-ehhedrine free base was used and may
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suggest that the ephedrine decomposes back to PAC on 
contact with the hydrochloride gas. A more sophisticated 
system which has the capacity to measure the quantity of 
gas added may overcome this problem, and increase the 
purity and yield of hydrochloride derivative produced.
Many authors have published work relating to the synthesis 
of ephedrine analogues, but in all these cases the product 
was formed as a racemic mixture. As a result of this no 
optical rotation measurements are available. While all the 
erythro and threo compounds synthesised in this research 
were observed to be laevorotary, no figures for the 
compounds purity can be drawn from this data.
The melting point data was used as an indication of the 
compound purity and in the case of ephedrine and the
4-chloroephedrine isomers it agreed completely with the 
published figures. The other analogues agreed with the 
published melting point data to a varying degree, yet they 
all gave very acceptable microanalysis results. This is 
consistent with compounds which may be chemically pure but 
not fully optically pure.
High field 1H nmr was used to give more detailed information 
on the purity of the compounds. The (-) ephedrine produced 
by the method of synthesis described in this research was 
indistinguishable from the commercial ephedrine using this
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nmr technique. The application of chiral shift reagents 
caused the C-CH3 band to shift upfield but the band 
multiplicity remained unchanged. Inspection of this data 
suggests that the fractional crystallisation step 
successfully separated the diastereoisomer pairs and the 
resulting fractions were present as single enantiomers. The 
orientation of the hydroxyl group on carbon 1 must 
therefore remain stable through out the reductive amination 
reaction. The high field nmr data for the unresolved 
synthetic ephedrine mixture indicated only slight 
stereoselectivity during the reduction at carbon 2 .
The pharmacological testing of the ephedrine analogues gave 
some information on the potential antispasmodic activity of 
these compounds. The initial attempt did not yield any 
results and this was explained by the age of the rabbit 
tissue used. The subsequent trials were more successful and 
gave results which allow a tentative comparison of activity 
of the analogues with that of commercial (lR,2S)-{-)- 
ephedrine hydrochloride.
These experiments suggest that (-)-4-chloroephedrine 
hydrochloride may be a stronger antispasmodic than 
(-)-ephedrine hydrochloride, and that (-)-4-fluoro and 
(-)-4-methylephedrine hydrochloride have a similar activity 
to the commercially prepared control. Of these two 
synthesised compounds the former has a stronger activity.
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While synthesis of these substituted ephedrine compounds 
may find useful application as antispasmodics, it is more 
likely that they may be used as chiral precursors for the 
synthesis of other molecules. One such application would be 
in the preparation of the antidepressant compounds 
(tri-substituted oxazolidin-2-one oximes) described by 
Ziman20. The activity of these compounds could possibly be 
enhanced if they were prepared stereoselectively.By using 
the method of synthesising (1R,2S) ephedrines analogues 
described in this research, this type of preparation is 
possible.
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EXPERIMENTAL
3.1 MATERIALS
The aromatic aldehydes used in the fermentations were 
obtained from Aldrich chemicals, Dorset, with the exception 
of benzaldehyde and 4-methylbenzaldehyde which were 
supplied by Riedel de Haen and Merck respectively. The 
materials used to prepare the fermentation medium were 
sodium pyruvate and Peptone from Sigma Chemicals, St. 
Louis,USA., citric acid from Riedel de Haen, and glucose 
monohydrate (Food Grade) from Roquette Chemicals. The yeast 
used was "Proofex" compressed bakers yeast supplied by 
Irish Yeast Products, Glasnevin.
The sodium cyanoborohydride and methylamine hydrochloride 
were both supplied by Aldrich Chemicals, Dorset, and the 
four commercial ephedrine standards were also supplied by 
Aldrich Chemicals ie (1R,2S)-(-)-ephedrine, (lS,2R)-(+)-
ephedrine hydrochloride, (1R, 2R) - ( -)-i|r-ephedrine, and 
(IS, 2R) - (+) -ijr-ephedrine hydrochloride.
The Kieselgel S (.032-.063 mm) Silica gel, and the pre­
coated TLC plated were obtained from Riedel de Haen, while 
the deuterated solvents used in the nmr study were supplied 
by Aldrich Chemicals.
The chiral lanthanide shift reagents used in the high field 
nmr study were supplied by Aldrich Chemicals,and all other 
reagents and solvents used were general purpose reagents.
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3.2 FERMENTATION OF AROMATIC ALDEHYDES
The selected medium was prepared as described in 
appendix I . The ingredients were dissolved in tap water 
and the pH adjusted to within the range 4.4 to 4.6 by the 
dropwise addition of sodium hydroxide soln. (40% w/v). The 
temperature of the medium was adjusted to 29°C and placed 
in the fermentation vessel figure in the water bath 
(previously heated to 29°C ). Fresh bakers yeast
(Saccharomyces Cerevisiae) (30g) was added and the aeration 
and stirring mechanism were started. After an initial 
period of one hour fermentation the aromatic aldehyde 
substrate was added to give a concentration of 16mM. In the 
case of some of the less soluble substituted 
benzylaldehydes eg. 4-Chlorobenzylaldehyde it was necessary 
to dissolve them initially in acetone and add a fixed 
aliquot to give the desired concentration. Hourly additions 
of the substrate were continued until a total fermentation 
time of 4 hours was reached.The medium was then inoculated 
with extra yeast (20g) and the process of substrate 
additions continued until a total of 7 additions were made. 
Fermentation was continued for an extra hour before 
extraction of the medium.
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Figure 3. Fermentation equipment used during the 
preparation of the aromatic carbinols
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3.3 EXTRACTION OF CABINOL FROM MEDIUM
The medium was centrifuged at 6000g for five minutes to 
remove the yeast cells from suspension. The supernatant 
liquid was removed by suction taking care not to disturb 
the semi solid layer of cells at the bottom, which were 
then extracted twice with ethanol (40 cm3) and filtered. The 
ethanol extract was added to the aqueous layer and 
transferred to a large separation funnel where it was 
extracted twice with equal volumes of diethyl ether. This 
was reduced to 50 cm3 by rotary evaporation to give a yellow 
liquid, which was washed twice with equal volumes of 10% 
Na2C03. The ether layer was dried over magnesium sulphate 
and evaporated under reduced pressure to give a thick 
opaque liquid. This was maintained at reduced pressure for 
one hour to remove all traces of solvent prior to 1H nmr 
spectroscopy.
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3.4 PURIFICATION OF CRUDE PAC
The crude material was dissolved in ether to give complete 
solution. This was extracted twice with equal volumes of a 
10% solution of sodium metabisulphate. The aqueous layer 
was removed and washed with ether to extract any remaining 
alcohol. Solid sodium hydrogen carbonate was added to 
decompose the organic-bisulphate complex resulting in the 
release of carbon dioxide. When the effervescence had 
ceased the carbinol was re-extracted into ether. The phenyl 
acetylcarbinol was recovered by rotary evaporation of the 
solvent.
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3.5 THIN LAYER CHROMATOGRAPHY
The pre-coated chromatography plates were cut to size and 
marked to show a thin pencil line at a hight just above the 
solvent height. Solid samples were dissolved in a suitable 
solvent prior to loading on the plates, otherwise neat 
liquid samples were used. The plate was dried in air and 
the location and identification of each spot was marked. 
The plate was then placed vertically in the chromatography 
chamber. When the solvent front had travelled about 7cm the 
plate was removed and dried in air. The dried plates were 
developed with iodine and the Rf values calculated.
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3.6 COLUMN CHROMATOGRAPHY
A clean dry glass separating funnel was packed with cotton 
wool at the neck above the tap. Silica gel (Kieselgel S 
0.032-0.063 mm ) approximately 50g was weighed and mixed 
with the elution solvent to give a thick paste. This was 
slowly poured down the side of the funnel and the side
tapped gently to remove any air bubbles in the gel. The
solvent level was increased and the tap opened to allow a 
small trickle to elute. When necessary the solvent level
was increased to insure that the column did not dry out.
This was achieved using a Pasteur pipette and letting the 
solvent flow down the side without disturbing to top layer 
of the gel. The column had compacted to about half the 
original volume on standing for three hours, and a layer of 
sand was placed on the top of the gel.
The level of elutant in the column was dropped to just 
above the top of the sand layer, and the sample 
(dissolved in a suitable solvent) was loaded onto the top 
of the column using a pipette. Extra elutant was 
immediately added to prevent the column from drying, and 
when the sample had entered the silica gel the eluent 
reservoir was filled . This reservoir level was maintained
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while the eluting solvent was collected in marked test 
tubes. The solvent in these was removed by rotary 
evaporation and thin layer chromatography was applied to 
each fraction to find the sections which contained the 
desired compound. These sections were combined and the 
compound recovered.
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3.7 REDUCTIVE AMINATION
Methylamine hydrochloride (60mM) was dissolved in dry 
methanol (60cm3) and added to a solution of the selected 
carbinol (lOmM) in the same solvent. Sodium 
cyanoborohydride (7mM) was added to the above mixture and 
extra solvent introduced to insure complete solution of the 
compound. The flask was capped and stirred for 72 hours at 
room temperature, and then acidified with conc. HC1 (3 cm3) 
in a fume cupboard. When the effervescence had ceased the 
solvent was removed under reduced pressure at 40°C to give 
a sticky white solid. This was dissolved in water (20 cm3) 
and washed twice with equal quantities of ether. It was 
basified with KOH pellets and saturated by the addition of 
sodium chloride, the liberated free base removed by 
extraction into ether (100cm3) , and the volume reduced by 
rotary evaporation. The free base was recovered as a yellow 
oil in all cases.
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3.8 PREPARATION OF THE HYDROCHLORIDE DERIVATIVE
The carbinol compound was dissolved in methanol (20cm3) and 
hydrochloric acid was added (3 cm3). The mixture was
refluxed for 30 minutes and the solvent and excess acid 
removed by rotary evaporation, leaving the solid 
hydrochloride derivative behind.
MODIFIED METHOD
Due to decomposition the yields experienced with the 
method described above were very low. It was modified by 
dissolving the ephedrine compound in diethyl ether and 
bubbling hydrogen chloride gas through the solution for 10 
minutes. The hydrochloride derivative was insoluble in this 
solvent in all but one case, and fell out of solution as a 
white solid. The solvent was removed by rotary evaporation 
and the product was recovered and purified.
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3.9 SEPARATION OF ISOMERS BY FRACTIONAL CRYSTALLISATION
The selected solvent, or solvent mixture, was heated to 
boiling point and the compound was placed in a pre-heated 
beaker (lOmL or 20mL depending on size of sample). The 
solvent was added dropwise to the compound and any 
dissolution was observed. More solvent was added as 
necessary until the compound had just dissolved. The 
solution was quickly filtered through a warm funnel to 
remove the insoluble compound, and the filtrate was 
collected. When the filtrate had cooled the resulting 
crystals were removed by filtration and washed. The 
original filtrate was let stand to produce a second yield 
of crystals which were treated in the same manner as the 
first yield. Each of the separated compounds were 
recrystallised from suitable solvents and their purity 
assessed by determining their melting points 
(section 3.10.1). When necessary the compounds were 
recrystallised a number of times untill no further change 
was observed.
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3.10 INSTRUMENTATION METHODS
3.10.1 Determination of melting point
The melting point of all the solid compounds were 
determined using a Griffet Melting Point Apparatus. The 
temperature was recorded from a mercury thermometer, which 
had previously been calibrated.
3.10.2 Determination of optical rotation
The optical rotation of the samples were measured using an 
Optical Activity, digital, electrically balancing 
instrument. A sample of the compound was weighed and 
dissolved in a known quantity of a suitable solvent. The 
machine as set to read zero using the solvent, and the cell 
was loaded with the sample solution. The observed rotation 
was noted and if this was less than the measurement 
accuracy (.05) a different cell or a more concentrated 
solution was tried. The machine was calibrated using L- 
cysteine.
3.10.3 Determination of 1H nmr data
The low field 1H nmr spectrum was recorded on a Perkin Elmer 
R-12B 60 Hz instrument.The samples were prepared by
dissolving in an appropriate solvent and loading the 
solution in a nmr tube (5 mm). This was warmed to operating 
temperature and set spinning in the magnetic field. 
Collecting and intergrating the nmr data was performed 
according to the manufacturers instructions for the 
instrument.
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3.10.4 Determination of high field nH nmr data
The high field 1H nmr was run on a Buker Ac-400 at 400MHz. 
The solutions were made up in deuterated chloroform and the 
residual hydrogen peak was used as a reference and assigned 
7.24ppm. The chiral shift reagent was tris(3-
(trifluoromethylhydroxymethylene)-d-camphorato) 
Paresodymium (HI) which was purchased from Aldrich 
chemicals. This was added to the deuterated chloroform 
solution in known quantities (0.5-lmg) and the chemical 
shift observed. All the operating /Shimming, and plotting 
operations were under software control.
The hydrochloride derivatives of ephedrine do not dissolve 
to any appreciable extent in this deuterated solvent and 
must be converted back to the free base before the nmr data 
can be collected. This is achieved by basifying an aqueous 
solution of the compound with sodium hydroxide and 
extracting with diethyl ether. The ether is dried over 
magnesium sulphate before evaporating the solvent.
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3.11 PHARMACOLOGICAL ACTIVITY
Fresh Thyroid solution was prepared and the bath reservoirs 
filled. A large rabbit was killed by cervical dislocation 
extrangulation and dissected. The jejunum was removed and 
placed in the thyroid solution while the three tissue baths 
(10cm3) reached the operation temperature (36°C). The 
Poligraph was switched on and the electrodes calibrated 
using a 2g weight, setting the full scale deflection to 8g. 
Lengths of tissue (1 cm) were removed from the stomach end 
of the jejunum and were suspended from the electrode by 
threads at either ends.
The bath was filled with pre-heated thyroid solution from 
the reservoir and the tissue adjusted to 2g tension by 
observing the position of the pen on the graph and 
adjusting the vertical height of the electrode. The 
solution in the bath was aerated with a mixture of oxygen 
/carbon dioxide, and the tissue spasms recorded on the 
graph. The gain control was used to maintain the 
contractions within the calibrated range, and when these 
spasms had stabilised the test sample was added 
(0.3 cm3 of 10'3M aqueous soln.) . The effect that this had
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on the contractions was observed by the change in the 
graph. After 10 minutes the bath was washed out with 
thyroid solution, and when the tissue stabilised again a 
different quantity of the test compound was added to 
ascertain the dose related response. This procedure was 
repeated with fresh tissue sections for each of the test 
compounds. Each of the compounds were tested on the tissue 
in the three baths.
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APPENDIX
APPENDIX I
FERMENTATION MEDIUM
MEDIUM A
For 800 cm3 of medium the following ingredients were weighed 
and diluted with tap water.
* Peptone 4.8g
* Sodium pyruvate 49.3g
* Citric acid 8.4 g
The pH was adjusted to 4.5 by the addition of 40% sodium
hydroxide solution.
MEDIUM B
For 800 cm3 of medium the following ingredients were weighed 
and diluted with tap water.
* Peptone 4.8g
* Sucrose 80g
* Citric acid 8.4 g
The pH was adjusted to 4.5 by the addition of 40% sodium
hydroxide solution.
MEDIUM C
For 800 cm3 of medium the following ingredients were weighed
and diluted with tap water.
* Yeast extract 4 . 8g
* Sucrose 80g
* Ammonium sulphate 7 . 32g
* Magnesium Sulphate 0 . 4g
* Potassium dihydrogen phosphate 0 . 8g
The pH was adjusted to 5.5 by the addition of 40% sodium 
hydroxide solution.
MEDIUM D
For 800 cm3 of medium the following ingredients were weighed
and diluted with tap water.
* Peptone 4. 8g
* Sucrose 80g
* Sodium pyruvate 20g
* Citric acid 8 . 4g
* Ammonium sulphate 7. 3g
* Magnesium Sulphate 0. 4g
* Potassium dihydrogen phosphate 0 . 8g
The pH was adjusted to 4.5 by the addition of 40% sodium 
hydroxide solution.
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Figure 4
60 MHZ nmr of phenyl acetyl carbinol in CDC13, compound purified by 
column chromatography. Instrument : Perkin Elmer R 12B
• «
Figure 5
60 MHz nmr of A methoxy ephedrine hydrochloride in deuterated water. 
Instrument : Perkin Elmer R 12B
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Figure 6.
400 MHz nmr of the product from the reductive amination 
of PAC.
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Figure y
400MHZ nmr of (— ) ephedrine synthesised by the reductive amination of PAC, in CDC13,
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Figure 8
400 MHz nmr of commercial ephedrine (Aldrich Chemicals), in CDC13 ,
Figure g
«OOMHz * .  of racemic ephearlne ln CDC13_ pesiduai ^
B) sample + lmg Pr(tfc)3
C) sample + 2mg Pr(tfc)3
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FIGURE H Trace of tissue spasm for conmercisl (1R 2S)-ephedrine hydrochloride at a concentration 
of 3x1O'3 H
i
f tissue «-s- for (1R 2 S ) - 4 - f luoroephedrine hydrochloride -t . concentrate 
FIGURE I? Trace of tissue »pas» Tor
of 3x1O'3 M
 t“1
for m  2S)-4-chloroephedrine hydrochloride at a concentration 
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